Biotech · Private company · Van Nuys, CA, US
Mabswitch, Inc.
Track this companyFree. Adds Mabswitch, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Remote-Controlled PC-CAR T-Cell Therapy for Hard-to-Treat Solid TumorsFiscal year 2026 · $400KNIH RePORTER 1R43CA310118-01 · fetched Nov 12, 2026
- Affinity-tunable Antibody Drug Conjugate (ADC) against High-Grade Serous Ovarian CancerFiscal year 2026 · $400KNIH RePORTER 1R43CA314526-01 · fetched Nov 12, 2026
- LentiSAFE Ligands: Mild-Elution Immunoaffinity Ligands for Enrichment and Purification of Lentiviral VectorsFiscal year 2024 · $339KNIH RePORTER 1R43TR004551-01A1 · fetched Nov 12, 2026